Otofarma S.p.A. Logo

Otofarma S.p.A.

Provides tailored hearing solutions and remote diagnostics through a partner pharmacy network.

OTO | Euronext Growth

Overview

Corporate Details

ISIN(s):
IT0005663361
LEI:
815600FED560ACA5D783
Country:
Italy
Address:
N/A
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Otofarma S.p.A. is an Italian company that specializes in the design, manufacture, and marketing of custom hearing aids and related accessories. The company provides personalized otoacoustic medical devices, including in-the-ear (Endoauricular) and behind-the-ear (Retroauricular) models, to address hearing loss. A key part of its service offering is Teleaudiology, a telemedicine platform that facilitates remote otoscopic and audiometric examinations through a network of partner pharmacies. This allows specialists to prescribe and create precisely tailored hearing solutions for patients based on detailed diagnostic data. The company emphasizes its focus on comfort, discretion, and delivering a natural sound experience for its users.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Otofarma S.p.A. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-08 17:49
Share Issue/Capital Change
OTOFARMA: announcement of change in share capital following full exercise of gr…
English 353.3 KB
2025-09-08 17:47
Share Issue/Capital Change
OTOFARMA: comunicazione di avvenuta variazione del capitale sociale a seguito d…
Italian 355.3 KB
2025-09-05 18:03
Director's Dealing
Internal Dealing
Italian 88.5 KB
2025-09-02 18:17
Regulatory News Service
OTOFARMA: full exercise of the Greenshoe Option
Italian 320.7 KB
2025-09-02 18:14
Regulatory News Service
OTOFARMA: esercizio integrale dell’opzione greenshoe
Italian 347.4 KB

Automate Your Workflow. Get a real-time feed of all Otofarma S.p.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Otofarma S.p.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Integrum AB Logo
Develops bone-anchored implant systems for amputees to improve mobility and quality of life.
Sweden INTEG
Invent Medic Sweden AB Logo
A FemTech company developing sustainable, reusable products for continence and menstrual health.
Sweden IMS
IRRAS Logo
Develops innovative fluid exchange & ICP monitoring systems for neurocritical care patients.
Sweden IRRAS
Italia Independent Logo
Designs innovative Italian eyewear with unique materials for fashion-forward individuals.
Italy IIG
iVision Tech Logo
Designs and manufactures eyewear, assistive smart glasses, and precision optics for the auto industry.
Italy IVN
iZafe Group AB Logo
Develops medication robots and smart pillboxes for patient safety and clinical trial support.
Sweden IZAFE
Japan Eyewear Holdings Logo
Manages high-end Japanese eyewear brands, from design and manufacturing to global retail.
Japan 5889
Japan Lifeline Co., Ltd. Logo
Manufactures and distributes cardiovascular medical devices, including ablation and diagnostics.
Japan 7575
Japan Medical Dynamic Marketing, INC. Logo
Develops & sells orthopedic trauma, joint, and spine implants for hospitals primarily in Japan.
Japan 7600
JMS CO.,LTD. Logo
Global manufacturer of medical devices for infusion, dialysis, surgery, and cardiovascular therapies.
Japan 7702

Talk to a Data Expert

Have a question? We'll get back to you promptly.